Cargando…

Targeted delivery of doxorubicin to HER2 positive tumor models

BACKGROUND: Exosomes are natural nanovesicles with unique characteristics, such as long circulating half-life, the intrinsic ability to target tissues, biocompatibility, and minimal or no inherent systemic toxicity. Mesenchymal stem cells produce large amounts of exosomes with regenerative propertie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomari, Hosna, Forouzandeh Moghadam, Mehdi, Soleimani, Masoud, Ghavami, Mahlegha, Khodashenas, Shabanali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662522/ https://www.ncbi.nlm.nih.gov/pubmed/31413568 http://dx.doi.org/10.2147/IJN.S210731

Ejemplares similares

Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle
por: Gomari, Hosna, et al.
Publicado: (2018)

Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
Publicado: (2019)

Designer Exosomes: A New Platform for Biotechnology Therapeutics
por: Jafari, Davod, et al.
Publicado: (2020)

Comparison of the Ex Vivo Expansion of UCB-Derived CD34+ in 3D DBM/MBA Scaffolds with USSC as a Feeder Layer
por: Sadat Hashemi, Zahra, et al.
Publicado: (2013)

Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells
por: Kucharczyk, Kamil, et al.
Publicado: (2020)

Endoplasmic reticulum—Phagosome contact sites from the cradle to the grave
por: Ghavami, Mahlegha, et al.
Publicado: (2022)

Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
por: Yousefpour, Parisa, et al.
Publicado: (2011)

Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]
Publicado: (2022)

Editorial: Exosomes, miRNAs, and lncRNAs in breast cancer: Therapeutic and diagnostic applications
por: Hashemi, Zahra Sadat, et al.
Publicado: (2023)

Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors
por: Madhankumar, A. B., et al.
Publicado: (2018)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018)

Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo
por: Naseri, Zahra, et al.
Publicado: (2018)

Biocompatible and biodegradable fibrinogen microspheres for tumor-targeted doxorubicin delivery
por: Joo, Jae Yeon, et al.
Publicado: (2015)

Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics
por: Cavallaro, Palmira Alessia, et al.
Publicado: (2023)

Functional Concentrations of BMP4 on Differentiation of Mouse Embryonic Stem Cells to Primordial Germ Cells
por: Hamidabadi, Hatef Ghasemi, et al.
Publicado: (2011)

Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma
por: Dragojevic, Sonja, et al.
Publicado: (2019)

Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
por: Naik, Himgauri, et al.
Publicado: (2021)

Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model
por: Hafizi, Maryam, et al.
Publicado: (2019)

Doxorubicin-conjugated PLA-PEG-Folate based polymeric micelle for tumor-targeted delivery: Synthesis and in vitro evaluation
por: Hami, Zahra, et al.
Publicado: (2014)

A tumor cord model for Doxorubicin delivery and dose optimization in solid tumors
por: Eikenberry, Steffen
Publicado: (2009)

Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies
por: Koopaei, Mona Noori, et al.
Publicado: (2011)

Proliferation in culture of primordial germ cells derived from embryonic stem cell: induction by retinoic acid
por: Makoolati, Zohreh, et al.
Publicado: (2016)

In vitro germ cell differentiation from embryonic stem cells of mice: induction control by BMP4 signalling
por: Makoolati, Zohreh, et al.
Publicado: (2016)

Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
por: Farokhimanesh, Samila, et al.
Publicado: (2020)

Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes
por: Shi, Menghao, et al.
Publicado: (2018)

Phylogenetic Comparison of Influenza Virus Isolates from Three Medical Centers in Tehran with the Vaccine Strains during 2008-2009
por: Mousavi, Seyedeh Fahime, et al.
Publicado: (2011)

Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model
por: MacDiarmid, Jennifer A., et al.
Publicado: (2016)

Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors
por: Joseph, Manu M., et al.
Publicado: (2014)

HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery
por: Geng, Lingling, et al.
Publicado: (2016)

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou, Xiaoju, et al.
Publicado: (2012)

Multiscale Kinetic Modeling of Liposomal Doxorubicin Delivery Quantifies the Role of Tumor and Drug-Specific Parameters in Local Delivery to Tumors
por: Hendriks, B S, et al.
Publicado: (2012)

Design of Small Molecules with HIV Fusion Inhibitory Property Based on Gp41 Interaction Assay
por: Sardari, Soroush, et al.
Publicado: (2013)

Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells
por: Komedchikova, Elena N., et al.
Publicado: (2022)

Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
por: Griguolo, Gaia, et al.
Publicado: (2019)

Redox Potential Ultrasensitive Nanoparticle for the Targeted Delivery of Camptothecin to HER2-Positive Cancer Cells
por: K.C., Remant Bahadur, et al.
Publicado: (2014)

Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin
por: Kalimuthu, Senthilkumar, et al.
Publicado: (2018)

Getting Out or Remaining in the Cage of Inauthentic Self: The Meaning of Existential Challenges in Patients' with Cancer
por: Khoshnood, Zohreh, et al.
Publicado: (2018)

Body-Mind Healing Strategies in Patients with Cancer: a Qualitative Content Analysis
por: Khoshnood, Zohreh, et al.
Publicado: (2018)

Informational Needs of Patients with Cancer: A Qualitative Content Analysis
por: Khoshnood, Zohreh, et al.
Publicado: (2019)

Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery
por: Skalickova, Sylvie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pd8jd59pokd4cs5vo0l5br8f7m